Mepolizumab 100 mg in severe asthmatic patients with EGPA...

  • Main
  • 2020 / 10
  • Mepolizumab 100 mg in severe asthmatic patients with EGPA...
The Journal of Allergy and Clinical Immunology: In Practice 2020 / 10

Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase

Caminati, Marco, Crisafulli, Ernesto, Lunardi, Claudio, Micheletto, Claudio, Festi, Giuliana, Maule, Matteo, Giollo, Alessandro, Orsolini, Giovanni, Senna, Gianenrico
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Journal of Allergy and Clinical Immunology: In Practice
DOI:
10.1016/j.jaip.2020.09.025
Date:
October, 2020
File:
PDF, 218 KB
2020
Conversion to is in progress
Conversion to is failed